BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16769671)

  • 1. TLS, EWS and TAF15: a model for transcriptional integration of gene expression.
    Law WJ; Cann KL; Hicks GG
    Brief Funct Genomic Proteomic; 2006 Mar; 5(1):8-14. PubMed ID: 16769671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
    Chansky HA; Hu M; Hickstein DD; Yang L
    Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins.
    Morohoshi F; Arai K; Takahashi EI; Tanigami A; Ohki M
    Genomics; 1996 Nov; 38(1):51-7. PubMed ID: 8954779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and expression analysis in the developing embryonic brain of the porcine FET family: FUS, EWS, and TAF15.
    Blechingberg J; Holm IE; Nielsen AL
    Gene; 2012 Feb; 493(1):27-35. PubMed ID: 22143032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF(II)68 proteins.
    Guipaud O; Guillonneau F; Labas V; Praseuth D; Rossier J; Lopez B; Bertrand P
    Proteomics; 2006 Nov; 6(22):5962-72. PubMed ID: 17106916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains involved in TAF15 subcellular localisation: dependence on cell type and ongoing transcription.
    Marko M; Vlassis A; Guialis A; Leichter M
    Gene; 2012 Sep; 506(2):331-8. PubMed ID: 22771914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.
    Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA
    J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
    Mackenzie IR; Neumann M
    Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGG boxes within the TET/FET family of RNA-binding proteins are functionally distinct.
    Chau BL; Ng KP; Li KK; Lee KA
    Transcription; 2016 Aug; 7(4):141-51. PubMed ID: 27159574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of the novel monoclonal antibody against TLS/EWS-CHOP chimeric oncoproteins that is applicable to one of the most sensitive assays for myxoid and round cell liposarcomas.
    Oikawa K; Ishida T; Imamura T; Yoshida K; Takanashi M; Hattori H; Ishikawa A; Fujita K; Yamamoto K; Matsubayashi J; Kuroda M; Mukai K
    Am J Surg Pathol; 2006 Mar; 30(3):351-6. PubMed ID: 16538055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of fusion genes in adipocytic tumors.
    Kubo T; Matsui Y; Naka N; Araki N; Myoui A; Endo K; Yasui N; Ohtani O; Suzuki K; Kimura T; Yoshikawa H; Ueda T
    Anticancer Res; 2010 Feb; 30(2):661-4. PubMed ID: 20332486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
    Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
    Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.
    Sjögren H; Meis-Kindblom J; Kindblom LG; Aman P; Stenman G
    Cancer Res; 1999 Oct; 59(20):5064-7. PubMed ID: 10537274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited.
    Zinszner H; Immanuel D; Yin Y; Liang FX; Ron D
    Oncogene; 1997 Jan; 14(4):451-61. PubMed ID: 9053842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of RNA binding specificity for the TET-family proteins.
    Takahama K; Kino K; Arai S; Kurokawa R; Oyoshi T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):213-4. PubMed ID: 18776329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism.
    Anumanthan G; Halder SK; Friedman DB; Datta PK
    Cancer Res; 2006 Nov; 66(22):10824-32. PubMed ID: 17108118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc glycosylation stoichiometry of the FET protein family: only EWS is glycosylated with a high stoichiometry.
    Kamemura K
    Biosci Biotechnol Biochem; 2017 Mar; 81(3):541-546. PubMed ID: 27903134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
    Laflamme C; Filion C; Bridge JA; Ladanyi M; Goldring MB; Labelle Y
    Cancer Res; 2003 Jan; 63(2):449-54. PubMed ID: 12543801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins.
    Thomsen C; Grundevik P; Elias P; Ståhlberg A; Aman P
    FASEB J; 2013 Dec; 27(12):4965-74. PubMed ID: 23975937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions.
    Blechingberg J; Luo Y; Bolund L; Damgaard CK; Nielsen AL
    PLoS One; 2012; 7(9):e46251. PubMed ID: 23049996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.